Search for the latest updates on diabetes
News
Zafgen Announces Initiation of Phase 2b Trial of Beloranib in Severe Obesity GlobeNewswire via Yahoo! Finance - 11 minutes
BOSTON, Dec. 15, 2014 (GLOBE NEWSWIRE) -- Zafgen, Inc. (ZFGN), a biopharmaceutical company dedicated to significantly improving the health ...
Manage alerts · Unsubscribe · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Alerts. |
No comments:
Post a Comment